Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer's Shares Rise on Strong Q1 Results

NEW YORK (GenomeWeb News) – Shares of PerkinElmer climbed just above 15 percent in afternoon trading on the New York Stock Exchange following its announcement after the close of the market yesterday of strong first-quarter results.
PerkinElmer’s shares climbed as high as 20 percent to $27.25 during the trading session before settling back to $26.18 in the afternoon.
The firm reported revenues of $511.5 million for the quarter ended Dec. 30, 2007 — a 20 percent gain on its fourth-quarter revenues the year before. PerkinElmer also said that its quarterly profit jumped 26 percent to $52.6 million, or $.44 per share, which beat Wall Street estimates.
The firm’s shares rose after a couple of analysts published positive research notes on PerkinElmer, citing potential revenue growth from new products and acquisitions. The company recently spent around $300 million to acquire ViaCell, a Cambridge, Mass.-based specialty stem cell company.
PerkinElmer officials predicted during an October conference call that with the acquisition of ViaCell, the firm would grow its genetic screening revenue to around $500 million by 2010, up from roughly $270 million from the combined businesses of PerkinElmer and ViaCell in 2007.
Last month, PerkinElmer said it would buy Pediatrix Medical’s newborn metabolic screening business for an undisclosed amount.
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.